Sanofi (SNY) Assets (2009 - 2026)
Sanofi (SNY) posted Assets of $150.0 billion for Q2 2026, little changed sequentially from $149.9 billion in Q1 2026, and up 6.06% YoY from $141.4 billion in Q2 2025.
Sanofi (SNY) Assets (2009 - 2026) Analysis & Trends
Sanofi has reported Assets for 18 years, with the latest figure at $150.0 billion in Q2 2026.
- Quarterly Assets rose 6.06% year-over-year to $150.0 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $150.0 billion (up 6.06% YoY) and the FY2025 annual result came in at $147.6 billion, up 4.02% from the prior year.
- Assets held at $150.0 billion in Q2 2026 per SNY's latest filing, from $149.9 billion in the prior quarter.
- Over five years, Assets peaked at $151.7 billion in Q3 2025 and troughed at $129.3 billion in Q4 2022.
- A 5-year average of $141.1 billion and a median of $140.6 billion in 2025 frame the typical range for Assets.
- The sharpest annual moves came in 2022 and 2026: Assets decreased 6.01% in 2022, then increased 8.04% in 2026.
- Over 5 years, Assets stood at $129.3 billion in 2022, then increased by 5.24% to $136.1 billion in 2023, then increased by 4.29% to $141.9 billion in 2024, then rose by 4.02% to $147.6 billion in 2025, then increased by 1.63% to $150.0 billion in 2026.
- According to Business Quant data, Assets over the past three periods registered $150.0 billion, $149.9 billion, and $147.6 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 648.58 Bn | 627.82 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 466.01 Bn | 459.44 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 375.19 Bn | 368.05 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 300.09 Bn | 292.40 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 256.64 Bn | 251.74 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 235.38 Bn | 221.39 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 180.78 Bn | 177.60 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 159.94 Bn | 148.24 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Gsk | 105.22 Bn | 101.06 Bn | 8.24 Bn | 82.83 Bn |
| 10 | Sanofi | 54.77 Bn | 47.39 Bn | 10.79 Bn | 150.01 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 150.01 Bn |
| Mar 31, 2026 | 149.88 Bn |
| Dec 31, 2025 | 147.61 Bn |
| Sep 30, 2025 | 151.74 Bn |
| Jun 30, 2025 | 141.45 Bn |
| Mar 31, 2025 | 138.74 Bn |
| Dec 31, 2024 | 141.91 Bn |
| Jun 30, 2024 | 139.73 Bn |
| Dec 31, 2023 | 136.07 Bn |
| Jun 30, 2023 | 136.50 Bn |
| Dec 31, 2022 | 129.29 Bn |
| Jun 30, 2022 | 130.00 Bn |
| Dec 31, 2021 | 137.55 Bn |
| Jun 30, 2021 | 135.26 Bn |
| Dec 31, 2020 | 136.41 Bn |
| Jun 30, 2020 | 127.57 Bn |
| Dec 31, 2019 | 1.75 Bn |
| Jun 30, 2019 | 124.21 Bn |
| Dec 31, 2018 | 127.16 Bn |
| Sep 30, 2018 | 1.85 Bn |